SCHEMBL29314248

SCHEMBL29314248

CC(C)(C)CCc1ccc(CCC(C)(C)C(=O)O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC13A5 Q86YT5 3/20 0.46
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
PPARA Q07869 3/20 0.42
SLC6A2 P23975 1/20 0.41
MMP12 P39900 1/20 0.41
MMP13 P45452 1/20 0.41
LTB4R Q15722 2/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
BLM P54132 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22921420 0.94 SLC13A5 (0.50) SLC13A5CYP1A2CYP2C9PPARASLC6A2
SCHEMBL15496714 0.86 PPARA (0.48) SLC13A5CYP1A2CYP2C9PPARALTB4R
SCHEMBL25996884 0.86 SLC13A5 (0.45) SLC13A5CYP1A2CYP2C9PPARASLC6A2
SCHEMBL173883 0.86 CYP1A2 (0.51) SLC13A5CYP1A2CYP2C9PPARALTB4R
SCHEMBL30080837 0.86 CYP1A2 (0.51) SLC13A5CYP1A2CYP2C9PPARALTB4R
SCHEMBL24440172 0.85 GRM2 (0.50) SLC13A5
SCHEMBL11961980 0.85 SLC13A5 (0.44) SLC13A5CYP1A2CYP2C9PPARASLC6A2
SCHEMBL2223565 0.85 PPARA (0.49) SLC13A5CYP1A2PPARA
SCHEMBL28246708 0.84 LTB4R (0.50) SLC13A5CYP1A2CYP2C9PPARALTB4R
SCHEMBL26060087 0.83 LTB4R (0.53) CYP1A2CYP2C9PPARALTB4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4003314-B1 FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC ACIDS USEFUL FOR THE PREVENTION OR TREATMENT OF DISEASE ESPERVITA THERAPEUTICS INC (US) 2024-07-10 EP disclosed